Colgate-Palmolive Company

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +35

Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy

Dividend AI-generated analysis

πŸ“ˆ Colgate-Palmolive has increased its dividend for 63 consecutive years, earning its status as a 'Dividend King' with an uninterrupted payment history dating back to 1895.

🦷 The company maintains dominant market share in oral care, holding 41.3% of the toothpaste market and 32.7% of the manual toothbrush sector in Q2 2026.

🐾 Hill's Science Diet is a major growth driver within the Pet Nutrition segment, capitalizing on consumers' willingness to pay premium prices for pet health.

πŸ’° Operating cash flow reached $1.742 billion in the first six months of 2026, providing ample liquidity for dividend payments and business reinvestment.

πŸ“‰ The stock trades at a forward P/E of approximately 21x, reflecting a substantial premium valuation that limits potential upside if earnings growth decelerates.

πŸ’΅ CL offers a current dividend yield of roughly 2.5% based on a share price near $86, which is lower than yields available in the broader bond market.

πŸ“Š The earnings payout ratio stands at about 84%, indicating that a large portion of reported profits is distributed to shareholders rather than retained for growth.

βš–οΈ Compared to Procter & Gamble (PG), Colgate-Palmolive is considered a cheaper investment despite similar forward P/E multiples, as it is expected to grow faster.

πŸ›‘οΈ The business model relies on essential daily habits like brushing teeth and cleaning homes, providing a stable revenue stream resilient to economic downturns.

Bullish Signals
  • Colgate-Palmolive has increased its dividend for 63 consecutive years since 1963, establishing a robust track record of shareholder returns.
  • The company holds a commanding 41.3% market share in the toothpaste sector and 32.7% in manual toothbrushes, ensuring stable revenue from essential products.
  • Hill's Science Diet is a highly profitable pet nutrition brand that benefits from consumers' willingness to pay premium prices for veterinary-recommended food.
  • Operating cash flow of $1.742 billion in H1 2026 demonstrates strong liquidity, allowing the company to sustain high dividend payouts and fund reinvestment.
  • The stock is viewed as a top-tier 'Dividend King' by hedge funds, offering consistency and reliability for long-term investors prioritizing stability over high yield.
Risk Factors
  • The stock trades at a forward P/E of approximately 21x, representing a substantial premium valuation that leaves little room for error if earnings growth slows.
  • The current dividend yield of roughly 2.5% is considered conservative and may not meet the income needs of investors seeking high immediate returns compared to bonds.
  • High valuation multiples imply that a fall in stock price could wipe out gains, even if the underlying business continues to perform reasonably well.
Full Analysis
Colgate-Palmolive (NYSE:CL) is analyzed as a top-tier 'Dividend King' stock, having increased its dividend for 63 consecutive years since 1963. The company derives revenue from three main segments: Oral Care, Personal Care/Home Care, and Pet Nutrition, with Hill's Science Diet being a key asset in the pet sector. Financial metrics indicate that CL maintains a strong market position, holding a 41.3% share of the toothpaste market and 32.7% of the manual toothbrush sector as of Q2 2026. The company generated $1.742 billion in operating cash flow during the first half of 2026, supporting its ability to sustain dividend payments while managing capital expenditures. Despite its robust fundamentals and predictable business model driven by essential consumer habits, CL trades at a premium valuation with a forward P/E ratio of approximately 21x. The current yield is around 2.5%, which the article suggests may be insufficient for investors seeking high immediate income compared to government bonds or other dividend stocks. Analysts note that while CL offers consistency and brand strength, its stock price carries a significant premium that limits upside potential if earnings growth slows. The company is viewed as a solid long-term hold for portfolios prioritizing stability over high yield, though investors are cautioned about valuation risks relative to peers like Procter & Gamble.